Lukas Biomedical Inc. (TPEX:6814)
Taiwan · Delayed Price · Currency is TWD 26.70
0.00 (0.00%)
Mar 4, 2026, 12:57 PM CST
Lukas Biomedical Market Cap
Lukas Biomedical has a market cap or net worth of 1.12 billion as of March 3, 2026. Its market cap has increased by 2.30% in one year.
Market Cap
1.12B
Enterprise Value
1.22B
Revenue
180.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.70
Market Cap Chart
Since December 31, 2020, Lukas Biomedical's market cap has decreased from 1.78B to 1.12B, a decrease of -37.02%. That is a compound annual growth rate of -8.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.12B | -13.87% |
| Dec 31, 2025 | 1.30B | 3.85% |
| Dec 31, 2024 | 1.25B | 15.69% |
| Dec 29, 2023 | 1.08B | -6.98% |
| Dec 30, 2022 | 1.16B | -15.47% |
| Dec 30, 2021 | 1.37B | -22.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.48B |
| Great Novel Therapeutics Biotech & Medicals | 1.46B |
| Enimmune | 1.31B |
| Meribank Biotech | 1.28B |
| GeneReach Biotechnology | 1.14B |
| Level Biotechnology | 1.09B |
| Holy Stone Healthcare | 1.02B |
| TCI GENE | 1.01B |